IP Library Granted Patent US 10,682,245
Granted Patent B2
US 10,682,245 · App. 15/351,282 · Granted Jun 16, 2020

Implantable biocompatible expander suitable for treatment of constrictions of body lumen

Inventors: Conor Harkin (Dublin, IE); Garrett Ryan (Dublin, IE); Bruce Murphy (Dublin, IE); James Redmond (Dublin, IE); Michael Burke (Dublin, IE); Riona Ni Ghriallais (Dublin, IE)
Assignee: The Provost, Fellows, Foundation Scholars, & The Other Members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth, Near Dublin
A61F2/86A61B1/307A61F2/04A61F2/848A61F2/966A61M29/02A61F2002/047A61F2002/825A61F2002/8483A61F2002/9665A61F2210/0004A61F2230/0013A61F2230/0023A61F2230/0054A61F2230/0056A61F2230/0067A61F2230/0069A61F2230/0095A61F2250/0039A61F2250/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,682,245
App. No.
15/351,282
Granted
Jun 16, 2020
Kind
B2
Abstract

An implantable biocompatible expander suitable for implantation into a urinary duct, comprises an elongated sinusoidal ring comprising at least two proximal prongs and at least two distal prongs, wherein the expander is resiliently deformable from a relaxed radially expanded orientation to a radially contracted orientation suitable for transluminal delivery through the urinary duct. The expander is configured to exert an outward radial force against a wall of the urinary duct when in-situ within the urinary duct. In particular, the expander is suitable for treatment of benign prostatic hyperplasia and configured for implantation into the prostatic urethra between, and substantially spanning the prostatic urethra between, the bladder neck and external sphincter.

Claims (7)

1. A method of treating benign prostatic hyperplasia in a mammal, which method employs an implantable biocompatible expander configured for resilient deformation and self-expansion from a radially contracted orientation suitable for transluminal delivery through a urinary duct to a radially expanded orientation capable of effecting in-situ dilation of the prostatic urethra, wherein the expander is configured to fit within the prostatic urethra between the bladder neck and the external sphincter and span at least 50% of the length of the prostatic urethra between the bladder neck and external sphincter, the method comprising the steps of implanting the expander into the prostatic urethra at a target location between the bladder neck and the external sphincter, whereby the expander in the radially expanded orientation effects in-situ dilation of the prostatic urethra between the bladder neck and the external sphincter without blocking the verumontanum, in which the implantable biocompatible expander is formed from a single elongated undulating ring, in which the single elongated undulating ring has three distal prongs and three proximal prongs providing a triangular cross-section that matches lateral triangular recesses of the urethra, allowing for differential flexing of the expander during use.

2. A method according to claim 1 , and comprising the steps of:

delivering the expander in a radially contracted orientation through the urethra to the target location within the prostatic urethra between the bladder neck and the external sphincter; and

allowing the expander to expand at the target location to a radially expanded orientation against the wall of the prostatic urethra with its proximal three prongs sitting anatomically in the triangularly shaped distal urethra.

3. A method according to claim 1 , in which the expander is configured to anatomically conform to the lumen of the prostatic urethra.

4. A method according to claim 1 , in which the length of the single elongated undulating ring is at least 10% greater than the width of the single elongated undulating ring when in a relaxed expanded state.

5. A method according to claim 1 , in which the single elongated undulating ring is a sinusoidal ring.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2025
From: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
To: PROVERUM LIMITED
Reel/Frame 073106/0480 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 043945 FRAME: 0622. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 5, 2020
From: HARKIN, CONOR; RYAN, GARRETT; MURPHY, BRUCE; REDMOND, JAMES; BURKE, MICHAEL; NI GHRIALLAIS, RIONA
To: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIV. TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
Reel/Frame 052569/0613 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2017
From: HARKIN, CONOR; GARRETT, RYAN; MURPHY, BRUCE; REDMOND, JAMES; BURKE, MICHAEL; GHRIALLAIS, RIONA NI
To: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIV. TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
Reel/Frame 043945/0622 →
Priority Claims (1)
EP 15194391 · Nov 12, 2015 · regional
Continuity (3)
Provisional Application 62321639 · Apr 12, 2016
Provisional Application 62254480 · Nov 12, 2015
Related Publication 20170135830A1 · May 18, 2017
Cited By (7)
US 12,201,542 US 12,329,663 US 12,357,479 US 12,390,320 US 12,485,257 US 12,655,445 US 12,678,308